FreMon Scientific, developer of ZipThaw and ZipSleeve next gen blood & tissue products warming and thawing technology, has submitted the Form 510(K) to the FDA and will have the initial CE Mark audit performed by the European Union on June 3.

ZipThaw’s CE Mark may be awarded as early as October 2018. As soon as CE Mark is approved FreMon Scientific will be prepared to bring the first of the new generation technology to market in all CE Mark countries. Discover the next generation dry, portable, lower-cost, cross contamination free warming and thawing technology at fremonscientific.com.